Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28712158 | 0.98 | CHRNB2 (0.49) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL9797252 | 0.86 | LMNA (0.60) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL6287551 | 0.85 | CHRNB2 (0.47) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL7738704 | 0.84 | CHRNA7 (0.51) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL1992997 | 0.83 | CHRNB2 (0.50) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL7619234 | 0.83 | CHRNB2 (0.46) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL123415 | 0.82 | MAPT (0.55) | NPC1CYP2C9CYP2C19HSD17B10MAPT | |
| SCHEMBL6416510 | 0.82 | NPC1 (0.46) | CHRNB2CHRNA7NPC1CYP2D6CYP2C9 | |
| SCHEMBL4905266 | 0.81 | TDP1 (0.59) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL6287587 | 0.81 | CHRNB2 (0.51) | CHRNB2CHRNA7CHRNB4CHRNA3CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101308-A1 | SEPARATOR FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | 삼성에스디아이 주식회사 | 2026-05-15 | — | — | WO | disclosed |
| EP-4742412-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4742410-A1 | SEPARATOR FOR RECHARGEABLE BATTERY AND RECHARGEABLE BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-13 | — | — | EP | disclosed |
| US-20260128467-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20260128462-A1 | SEPARATOR FOR RECHARGEABLE BATTERY AND RECHARGEABLE BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20260128465-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-07 | — | — | US | disclosed |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| US-12545780-B2 | Flexible metal clad laminates and methods of preparation thereof | NOTARK CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250367910-A1 | LAMINATES BASED ON COPOLYMERS OF DIISOALKENYLARENES | NOTARK CORPORATION (US) | 2025-12-04 | — | — | US | disclosed |
| US-12447719-B2 | Metal-clad laminate, wiring board, resin-including metal foil, and resin composition | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-10-21 | — | — | US | disclosed |
| EP-1481981-B1 | Styrene hypophosphite adduct, preparation thereof and use | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2007-08-15 | — | — | EP | disclosed |
| US-20070155923-A1 | Soluble polyfunctional vinyl aromatic polymer and method of producing the same | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1741703-A1 | PYRIDONE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-6900273-B1 | Low-hygroscopicity low-birefringence resin compositions, molding material obtained therefrom, sheet or film, and optical part | HITACHI CHEMICAL CO., LTD. (JP) | 2005-05-31 | — | — | US | disclosed |
| EP-1481981-A2 | Styrene hypophosphite adduct, preparation thereof and use | Clariant GmbH (DE) | 2004-12-01 | — | — | EP | disclosed |
| US-20040220342-A1 | Low-hygroscopicity low-birefringence resin compositions, molding material, sheet or film obtained therefrom, and optical part | YAMASHITA YUKIHIKO (JP) | 2004-11-04 | — | — | US | disclosed |
| EP-0780732-B1 | Polymer composition and resist material | WAKO PURE CHEM IND LTD (JP) | 2003-07-09 | — | — | EP | disclosed |
| EP-1205517-A1 | LOW-HYGROSCOPICITY LOW-BIREFRINGENCE RESIN COMPOSITIONS, MOLDING MATERIAL OBTAINED THEREFROM, SHEET OR FILM, AND OPTICAL PART | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2002-05-15 | — | — | EP | disclosed |
| US-5976759-A | ALKALI SOLUBLE BY HEATING | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1999-11-02 | — | — | US | disclosed |
| EP-0780732-A2 | Polymer composition and resist material | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1997-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128465-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | MMAB, HAT1, CD44 | CHRNB2 1065/4885CHRNA7 1123/4885CHRNB4 1423/4885 |
| US-20260128467-A1 | SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SMCHD1, SMC4, L1CAM | CHRNB2 1346/4885CHRNA7 1374/4885CHRNB4 1258/4885 |
| US-20260128462-A1 | SEPARATOR FOR RECHARGEABLE BATTERY AND RECHARGEABLE BATTERY INCLUDING THE SAME | ILK, SMCHD1, SMC4 | CHRNB2 562/4885CHRNA7 738/4885CHRNB4 426/4885 |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | PSMA1, PSMB10, RAD51 | CHRNB2 1295/4885CHRNA7 833/4885CHRNB4 1375/4885 |
| US-12545780-B2 | Flexible metal clad laminates and methods of preparation thereof | DSG1, CDH1, CAD | CHRNB2 921/4885CHRNA7 1425/4885CHRNB4 937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.